MID-VOLUME · HOSP-HEAVY
saxagliptin Side Effects
saxagliptin (also sold as Onglyza) sits MID-VOLUME #341 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 34.6% mention hospitalization (2,815 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 8,141
- FAERS reports
FDA Adverse Event Reporting System extract for saxagliptin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
saxagliptin: 34.6% mention hospitalization (2,815 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #341 of 524 by FAERS report count.
Mid-book FAERS page for saxagliptin (Onglyza) (8,141 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2007–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
CARDIAC FAILURE CONGESTIVE leads 428 of 8,141 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (1,860 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (648 reports, 8.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 233 |
| CARDIAC FAILURE CONGESTIVE | 66 |
| CARDIAC FAILURE | 58 |
| PNEUMONIA | 41 |
| PANCREATIC CARCINOMA | 39 |
| ACUTE KIDNEY INJURY | 27 |
| RENAL FAILURE | 22 |
| SEPSIS | 21 |
| CHRONIC KIDNEY DISEASE | 19 |
| PANCREATIC CARCINOMA METASTATIC | 19 |
| CARDIAC ARREST | 18 |
| ASTHENIA | 17 |
| CORONARY ARTERY DISEASE | 17 |
| DIARRHOEA | 17 |
| MYOCARDIAL INFARCTION | 17 |
| ANAEMIA | 16 |
| RENAL DISORDER | 16 |
| RESPIRATORY FAILURE | 16 |
| BLADDER CANCER | 15 |
| CARDIO-RESPIRATORY ARREST | 15 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (2,815, 34.6% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| CARDIAC FAILURE CONGESTIVE | 208 |
| CARDIAC FAILURE | 183 |
| PNEUMONIA | 139 |
| NAUSEA | 137 |
| VOMITING | 133 |
| ACUTE KIDNEY INJURY | 124 |
| DIARRHOEA | 123 |
| DYSPNOEA | 118 |
| DEHYDRATION | 108 |
| PANCREATITIS | 106 |
| WEIGHT DECREASED | 104 |
| ASTHENIA | 101 |
| FALL | 95 |
| MYOCARDIAL INFARCTION | 95 |
| DIZZINESS | 90 |
| ABDOMINAL PAIN | 88 |
| ANAEMIA | 86 |
| FATIGUE | 81 |
| DECREASED APPETITE | 79 |
| BLOOD GLUCOSE INCREASED | 77 |
How to read saxagliptin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 8,141 voluntary reports linked to saxagliptin (Onglyza), 2007-2025. Death is listed on 648 (8.0%). Hospitalization appears on 2,815 (34.6%). Top co-reported indication: Type 2 Diabetes Mellitus.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 34.6% mention hospitalization (2,815 reports).
Read with saxagliptin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 8,078 FAERS cases (Δ 63 lighter vs saxagliptin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 7,980 FAERS cases (Δ 161 lighter vs saxagliptin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 7,881 FAERS cases (Δ 260 lighter vs saxagliptin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 8,408 FAERS cases (Δ 267 heavier vs saxagliptin); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 54.1 pp vs saxagliptin's DEATH-HEAVY): CASELOAD · HOSP-MID.
saxagliptin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.